Doctors checked for hidden liver risk in COVID steroid treatment
NCT ID NCT07154212
Summary
This study looked at whether doctors followed guidelines to screen for hepatitis B in COVID-19 pneumonia patients before giving them steroid treatment. Researchers wanted to see if this hidden liver virus could reactivate and cause problems during COVID-19 care. They observed nearly 1,800 hospitalized adults who needed oxygen and received steroids for their COVID-19 pneumonia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Medical Centre Ljubljana
Ljubljana, Slovenia
Conditions
Explore the condition pages connected to this study.